Clinical Trials Browser

Withdrawn × Lymphoma, Follicular × efalizumab × Clear all

NCT00746980 2016-06-14

Efalizumab in the Treatment of Alopecia, Phase II

Phase 2 Withdrawn

Alopecia, Lymphoma, Follicular